- £875.56m
- £1.24bn
- €3.07bn
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Ireland's Uniphar 2025 revenue up 11%, beats estimates on strong demand in Global Sourcing
2025 Preliminary Results
Holding(s) in Company
Full Year Trading Update and Notice of Results
Holding(s) in Company
Brief: Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA for the Treatment of Niemann-Pick Disease Type C (NPC)
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Director/PDMR Shareholding